Galinpepimut-S (WT-1 Analog Peptide) Vaccine in Malignant Pleural Mesothelioma After Combined Modality Therapy
Clinical trial NCT01265433 · COMPLETED
Trial details
- NCT number
- NCT01265433
- Sponsor
- Sellas Life Sciences Group
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2010-12-21
- Primary completion
- 2016-11-30
- Enrollment
- 41
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.